Dealmaking

Chequers Capital snaps up Somacis from Green Arrow

Chequers has made the acquisition via its Chequers Capital XVII FPCI fund.

Ambienta exits SF Filter Group via Equistone

Equistone’s primary focus will be on bolstering the company’s existing growth trajectory, including through a targeted buy-&-build strategy.

General Atlantic’s Robb Vorhoff says the best entrepreneurs are playing long ball; how will employee ownership affect returns?

General Atlantic's healthcare head shares thoughts on PE-backed healthcare deals.

THCP and Atlantic Park-backed Borealis Hotel Group snaps up Bierwirth & Kluth

Atlantic Park invested in Borealis alongside THCP to finance the acquisition.

Copper Street exits Italian unicorn Satispay

Satispay's customer base has grown 800% since Copper Street's investment in 2018.

Friday Letter: Why there is an 'uptick in the premium' for climate tech companies

The co-author of a new climate tech report is unfazed by a slowdown in exits, saying the slump means climate tech companies "will just be more expensive for potential acquirers to buy."

Employee Ownership Programmes: How do they affect returns for LPs?

Employee ownership programmes, which seek to build wealth among company workers, are gaining traction in the private equity industry. Are investors losing out on upside, or benefitting from increased value creation?

ArchiMed backs PlasmidFactory; Labour shortages boost medtech deals

It is 'logical' for PE firms to look for opportunities in Europe, said John Kerins, managing director of Cain Brothers & Company, during a panel at HPE Europe.

Porsche shares rise; Eli Manning scores first PE deal; Orlando Bravo gives back to Puerto Rico

NFL legend Eli Manning scores his first PE deal.

ArchiMed backs German plasmid manufacturer PlasmidFactory

The investment is the second of ArchiMed’s MED Platform II, which began fundraising in January.